Aurinia Pharmaceuticals Inc.

AUPH · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$73,189$53,002$66,428$83,433
Short-Term Investments$278,619$262,131$246,473$275,043
Receivables$30,928$40,091$40,350$36,544
Inventory$44,793$46,503$46,195$39,228
Other Curr. Assets$11,208$7,243$6,316$12,348
Total Curr. Assets$438,737$408,970$405,762$446,596
Property Plant & Equip (Net)$84,797$89,453$94,107$98,871
Goodwill$0$0$0$0
Intangibles$3,901$4,046$4,158$4,355
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$93$93$823$823
Total NC Assets$88,791$93,592$99,088$104,049
Other Assets$0$0$0$0
Total Assets$527,528$502,562$504,850$550,645
Liabilities
Payables$2,214$3,312$4,220$5,187
Short-Term Debt$17,366$17,214$15,544$15,072
Tax Payable$0$0$0$0
Deferred Revenue$4,602$5,499$4,594$11,002
Other Curr. Liab.$52,038$52,241$44,048$66,502
Total Curr. Liab.$76,220$78,266$68,406$97,763
LT Debt$60,846$64,616$62,366$64,297
Deferred Rev, NC$12,249$12,349$12,450$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,442$12,030$11,438$11,107
Total NC Liab.$85,537$88,995$86,254$75,404
Other Liabilities$0$0$0$0
Cap. Leases$60,846$81,830$77,910$64,297
Total Liabilities$161,757$167,261$154,660$173,167
Equity
Pref Stock$0$0$0$0
Common Stock$1,116,797$1,122,582$1,163,262$1,187,696
Retained Earnings-$860,162-$891,713-$913,226-$936,570
AOCI-$749-$905-$825-$647
Other Equity$109,885$105,337$100,979$126,999
Total Equity$365,771$335,301$350,190$377,478
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$527,528$502,562$504,850$550,645
Net Debt$5,023$28,828$11,482-$4,064